🇺🇸 FDA
Patent

US 7906491

Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs)

granted A61KA61K31/7076A61P

Quick answer

US patent 7906491 (Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs)) held by Univisitair Medisch Centrum Utrecht expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Univisitair Medisch Centrum Utrecht
Grant date
Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61K, A61K31/7076, A61P, A61P29/00, A61P3/10